S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 18, 1997
April 24, 2020
b4092e3c-509e-4d7e-9f1c-4d7274985cc7
Related Documents
S1B Testing for Carcinogenicity of Pharmaceuticals
Guidance DocumentFebruary 23, 1998Center for Drug Evaluation and Research
S2B Genotoxicity: A Standard Battery for Genotoxicity Testing of Pharmaceuticals
Guidance DocumentNovember 21, 1997Center for Drug Evaluation and Research
Q2B Validation of Analytical Procedures: Methodology
Guidance DocumentMay 19, 1997Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.